CDSCO has listed Drugs, Medical Devices and Cosmetics declared as not of standard /quality /spurious/ adulterated /misbranded for February, 2019

The Central Drugs Standard Control Organization (“CDSCO”) has recently released, on their website, a list of drugs, medical devices and cosmetics declared as not of standard /quality /spurious/ adulterated /misbranded, for the month of February, 2019. They include the following:

  • Cefpodoxime Oral Suspension I.P. (Monopod)
  • Paracetamol Tablets I.P. (Larkin)
  • Cefixime & Lactic Acid Bacillus Tablets (Tixi-200 lb)
  • Pantoprazole Injection
  • Esopen – 20 (Esomeprazole Tablets I.P.)
  • Ketorolac Tromethamine Injection I.P. 1 ml
  • Leucovorin Calcium Injection I.P
  • Ranitac 150 (Ranitidine Hydrochloride Tablets I.P. 150mg)
  • Primaquine Tablets IP 7.5 mg (P-quine tablets)
  • Aceclofenac, Paracetamol and Serratiopeptidase Tablets (Hifein-sp tablets)

SourceCentral Drugs Standard Control Organization

Share this:

Sign up for our

Newsletter

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

Lexplosion will use the information you provide on this form to be in touch with you and to provide updates and marketing.